ArticleAmerican family physician2022

DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT-2 Inhibitors for People With Cardiovascular Disease.

Kento Sonoda et al.PubMed ↗

No numbers read from the abstract.